Skip to content

About Clinevo Technologies

The people behind Clinevo

Backed by a global investor network representing over $1.5 billion in assets under management.

Clinevo builds cloud software for drug safety, quality and clinical trials. It was founded by safety‑system veterans from Oracle, HCL and Accenture, and is led by Chief Executive Officer Rehan Netarwala and its board.

Established
2016
Clients
300+ in pharma, biotech, CROs and consumer health
Track record
10+ years in the industry, 55+ inspections
Offices
USA · UK · the Netherlands · India

01Leadership

Rehan Netarwala

Chief Executive Officer

Rehan Netarwala

A builder and operator, leading Clinevo into its next phase of growth.

Rehan has a track record of scaling businesses from the ground up. An engineer by training, he brings a systems-driven approach to growth, sharpened by an MBA from the Indian School of Business and early strategy work at Universal Consulting (L.E.K. India).

In 2017 he co-founded Savage & Palmer and built it into a business serving 500+ clients, leading it from founding to scale to exit. At Clinevo he builds on the company's foundation while preserving the domain expertise and client focus that define it.

Before Clinevo
Co-founder, Savage & Palmer, from founding to exit
Strategy
Universal Consulting (L.E.K. India)
Education
Engineer; MBA, Indian School of Business, Hyderabad

The team behind the product

The people who shape OnePV and lead its pharmacovigilance work with clients.

  • Ashish Bhandarkar

    Ashish Bhandarkar

    Vice President and Lead Subject Matter Expert, Pharmacovigilance

    Ashish leads Clinevo's pharmacovigilance expertise, guiding how OnePV handles case processing, automation and signal management. He speaks on trustworthy AI in signal management at the World Patient Safety Congress.

  • Prasanna Gurumoorthy

    Associate Director, Product Management

    Around 14 years in clinical research, pharmacovigilance and life‑sciences R&D IT. Prasanna joined Clinevo in 2018 as delivery lead and solutions architect, and now leads product management.

02Co-founders and strategic advisors

Clinevo was co-founded by two specialists who spent two decades in safety and clinical systems. They now advise the company.

  • Arun Govindasamy

    Arun Govindasamy

    Co-founder and Strategic Advisor

    Over 20 years in clinical and pharmacovigilance R&D IT. Arun held key roles in IT strategy and implementation before co-founding Clinevo, and continues to shape its strategic direction and growth.

    Worked with Novartis, Merck, Bayer and ICON · Previously Oracle, HCL Technologies and Cognizant

  • Arunkumar Devaraj

    Arunkumar Devaraj

    Co-founder and Strategic Advisor

    Over 20 years in pharmacovigilance R&D IT, specialising in safety system implementations and data migrations. His expertise in technology and client relations drives Clinevo's work with its clients.

    Worked with Novartis, Merck, Bayer and AbbVie · Previously Oracle, HCL Technologies and Accenture

03Investors and board

Backed by a global investor network representing over $1.5 billion in assets under management, and guided by a board of operators and investors.

Chaitanya Rathi

Board director

Chaitanya Rathi

Two decades as an operator and investor. Chaitanya was COO at Mswipe and at Sula Vineyards, where he played a key role in scaling the business and taking it public. He was Head of India at DSGCP Everstone, investing in early-stage companies, and holds an MBA from INSEAD.

Tycen Bundgaard

Board director

Tycen Bundgaard

Over two decades of strategic and operational leadership. Tycen is a former Partner at McKinsey & Company, where he spent 14 years advising businesses across Asia on strategy and growth, and a former CEO of Les Amis Group. He now leads Lighthaven, which supports companies across Asia as they scale.

04How we work

The completeness, validation and support of an enterprise safety suite, at a cost mid‑size teams can carry.

  1. i

    Domain first

    The people who design, configure and support our software have implemented and migrated safety systems for global pharma. Conversations start at case processing, coding and reporting rules.

  2. ii

    One platform, built in

    In OnePV, intake, literature, the safety database, signals, PV agreements and E2B(R3) submission share one case record and one audit trail.

  3. iii

    Validation included

    IQ/OQ/PQ validation is part of every engagement, not a paid add-on. Our software is built for 21 CFR Part 11, EU Annex 11, GxP and GAMP 5, and we are ISO 9001 and ISO 27001 certified and SOC 2 Type II audited.

  4. iv

    Technology with a reviewer

    Gen AI extracts case fields from the source and drafts the narrative; a case processor or safety physician reviews. Every field change is versioned and attributable, with e‑signature where required.

  5. v

    Support around the clock

    24/7 support from four offices, from implementation and data migration through to live submissions.

05Where we work

Four offices, one team. Someone is at work for our clients around the clock.

Daylight on the map and the local times are live.

  • USAClinevo Technologies America Inc.183 Broadway, Suite 210, Hicksville, New York 11801Local time
  • United KingdomClinevo Technologies UK Limited27a Green Lane, Northwood, Middlesex, HA6 2PXLocal time
  • The NetherlandsClinevo Technologies Europe B.V.Regus Tetra Hoofddorp, Siriusdreef 17‑27, 2132 WT HoofddorpLocal time
  • IndiaClinevo Technologies Private LimitedA-301, KSSIDC Complex I Block, 2nd Floor, Electronic City Phase I, Bengaluru, Karnataka 560100 · +91 98201 03201Local time